Streetbeat News

Assets

DBRG

Australia's Aware Super is partnering with DigitalBridge Group to invest in renewable-powered data centers. Aware Super will make a significant investment in Switch, a 100% renewable-powered data center platform, which was acquired by a DigitalBridge-managed investment entity last year.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 8:51 pm

YUM

Yum Brands Inc. (NYSE:YUM) has seen its shares fall by 1.18% over the past three months. The company's financial statement as of May 9, 2023, reveals a total debt of $11.75 billion, adjusted for $349.00 million in cash-equivalents, resulting in a net debt of $11.40 billion. The debt-ratio, considering Yum Brands's $5.75 billion in total assets, is at 2.04, indicating a large portion of debt is funded by assets.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 8:45 pm

LESL

Leslie's Inc (NASDAQ:LESL) shares dropped nearly 20% in after-hours trading following the release of preliminary Q3 results and the announcement of a CFO transition. The company's Q3 revenue is expected to be $611 million, significantly lower than the estimated $703.74 million. Adjusted earnings are anticipated to be between 39 cents and 41 cents per share, compared to estimates of 69 cents per share. The company also lowered its full-year 2023 revenue outlook. CFO Steve Weddell is stepping down and will be replaced by Scott Bowman.

Portfolio Pulse from Adam Eckert

July 13, 2023 | 8:31 pm

FANG

Over the past 10 years, Diamondback Energy (NASDAQ:FANG) has outperformed the market by 3.64% on an annualized basis, producing an average annual return of 13.98%. If an investor had bought $100 of FANG stock 10 years ago, it would be worth $369.69 today.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 8:30 pm

MTD

Mettler-Toledo Intl (NYSE:MTD) has outperformed the market over the past 15 years, producing an average annual return of 18.96%. If an investor had bought $1000 of MTD stock 15 years ago, it would be worth $13,860.84 today.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 8:30 pm

ATOS

Atossa Therapeutics, Inc. (NASDAQ:ATOS) has regained compliance with the Nasdaq minimum closing bid price requirement for continued listing on The Nasdaq Capital Market. The company was previously not in compliance due to its common stock failing to maintain a minimum closing bid price of $1.00 per share for 30 consecutive business days. The company has made significant progress with its (Z)-endoxifen development program and has over $100 million cash with no debt.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 8:18 pm

RIO

A significant investor has taken a bearish stance on Rio Tinto (NYSE:RIO), with 54% of recent trades being bearish and 45% bullish. The total amount for puts is $736,730 and for calls is $537,734. Whales have been targeting a price range from $60.0 to $94.38 for Rio Tinto over the last 3 months. The price of RIO is up 3.12% at $69.01, with RSI indicators suggesting it may be approaching overbought.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 8:16 pm

OLP

One Liberty Properties, Inc. (NYSE:OLP) has acquired a 177,040 square foot industrial distribution center in a suburb of Columbia, South Carolina for $13.4 million. The price includes the assumption of $4.3 million of mortgage debt. The property is leased to two tenants, providing an aggregate annual base rent of approximately $784,000, increasing approximately 3% annually. The company believes this acquisition will contribute to future cash flow growth.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 8:14 pm

IEI

The US federal deficit has increased by 170% to $1.39 trillion for the nine months through June, according to Treasury Department data. The cost of managing US government debt has risen by 25% to $652 billion in the first nine months of the fiscal year. The rise in interest rates has played a significant role in driving the deficit. The value of US Treasury bonds maturing in the next three to seven years, as monitored by the iShares 3-7 Year Treasury Bond ETF (NASDAQ:IEI), is 10% lower than it was at the beginning of 2022.

Portfolio Pulse from Piero Cingari

July 13, 2023 | 8:13 pm

ACAD

Acadia Pharmaceuticals has acquired the ex-North American rights to Trofinetide and global rights to Neuren's NNZ-2591 in Rett Syndrome and Fragile X Syndrome. The deal involves an upfront payment of $100M and additional milestones to Neuren.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 8:08 pm